APA (7th ed.) Citation

NF, C., J, D., JM, M., L, R., P, D., & ER, M. (2013). Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: Comparison of glycaemic control and pregnancy outcome. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 26(6), 588. https://doi.org/10.3109/14767058.2012.743523

Chicago Style (17th ed.) Citation

NF, Callesen, Damm J, Mathiesen JM, Ringholm L, Damm P, and Mathiesen ER. "Treatment with the Long-acting Insulin Analogues Detemir or Glargine During Pregnancy in Women with Type 1 Diabetes: Comparison of Glycaemic Control and Pregnancy Outcome." The Journal of Maternal-fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 26, no. 6 (2013): 588. https://doi.org/10.3109/14767058.2012.743523.

MLA (9th ed.) Citation

NF, Callesen, et al. "Treatment with the Long-acting Insulin Analogues Detemir or Glargine During Pregnancy in Women with Type 1 Diabetes: Comparison of Glycaemic Control and Pregnancy Outcome." The Journal of Maternal-fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, vol. 26, no. 6, 2013, p. 588, https://doi.org/10.3109/14767058.2012.743523.